ITE Live 1 (Adrenal, Bone, Pituitary, Thyroid)

Welcome to ITE Live 2021! There will be two webinars, intended to mimic the ITE Live session that occurs at the in-person ENDO each year. This course is for the first webinar, to take place on 5/12/2021, which will cover the Adrenal, Pituitary, Bone, and Thyroid questions from ITE 2021. The second webinar, to take place on 5/19, will cover the Diabetes, Lipids/Obesity, and Reproduction questions from ITE 2021.

Each webinar will have time reserved after each section for audience Q&A, and will be recorded and made available to all ITE 2021 participants.

Register today to participate in the ITE Live webinars!

Target Audience

This webinar will be of interest to fellows who participated in ITE 2021 and their program directors/associate program directors.

Learning Objectives

By the end of these webinars, fellows and their program directors will:

  • Better understand some of the more complex questions from ESAP-ITE 2021;
  • Identify important aspects of case-based questions seen in exams;
  • Walk through the rationale for solving case-based care questions.

Additional Information

Target Audience: 
Competency Area: 
Medical Knowledge
Practice-based Learning and Improvement
Topic Area: 
Adrenal/HPA Axis
Bone and Calciotropic Hormones
Neuroendocrinology and Pituitary
Thyroid/HPT Axis
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Activity summary
Course opens: 
Course expires: 


Ricardo Correa, MD
University of Arizona College of Medicine - Phoenix

Alan Chang, MD
Stony Brook University

Abeer Anabtawi, MD
University of Kansas

Partha Sinha, MD
Beth Israel Deaconess Medical Center

Nicholas Tritos, MD
Massachusetts General Hospital & Harvard Medical School

Ines Donanegelo, MD, PhD
UCLA Department of Medicine

Kristen Kobaly, MD
University of Pennsylvania 

Eve Bloomgarden, MD
Northwestern University


Elaine Pelley, MD (2020-2021 Program Chair)
University of Wisconsin Hospital and Clinics

Salila Kurra, MD (2021-2022 Program Chair)
Columbia University Irving Medical Center


As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s ITE Faculty Workgroup. 


The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (eg, stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivering content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported relevant financial relationships: Nicholas Tritos, MD: Consultant for Sandoz; institution-directed research support from Novartis.

The following faculty reported no relevant financial relationships: Elaine Pelley, MD; Salila Kurra, MD; Ricardo Correa, MD; Alan Chang, MD; Abeer Anabtawi, MD; Partha Sinha, MD; Ines Donangelo, MD, PhD; Kristen Kobaly, MD; Eve Bloomgarden, MD.

The Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.


The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the Endocrine Society.


The educational content in this self-assessment test relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available.


When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.


The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.


The Endocrine Society will record learner’s personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.


This activity is not supported by educational grant(s) or other funds from any commercial supporter.


To complete this activity, participants must have access to a computer or mobile device with an Internet connection and use a major Web browser, such as Internet Explorer 10+, Firefox 32+, Safari, or Google Chrome 37+. In addition, cookies and Javascript must be enabled in the browser’s options.